ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

Open Vet J. 2024; 14(9): 2368-2380


Survival outcomes, low awareness, and the challenge of neglected leptospirosis in dogs

Mookmanee Tansakul, Pimkhwan Sawangjai, Phassakorne Bunsupawong, Orapin Ketkan, Metawee Thongdee, Kridsada Chaichoen, Walasinee Sakcamduang.



Abstract
Download PDF Cited by 3 ArticlesPost

Background:
Leptospirosis is a globally neglected zoonotic disease with significant morbidity and mortality in dogs, particularly in resource-limited settings.
Aim:
This study aimed to characterize prognostic factors and survival outcomes in dogs with suspected leptospirosis, emphasizing the potential underestimation of disease burden.
Methods:
This retrospective study was conducted using medical records of dogs diagnosed with urinary Leptospira polymerase chain reaction (PCR).
Results:
Urinary Leptospira PCR was positive in 22 dogs and negative in 62. Azotemia was present in approximately two-thirds of both groups, with no predictive value identified between PCR-positive and PCR-negative dogs. However, PCR-positive dogs exhibited significantly shorter survival times for both all-cause mortality (median 60 days, range: 8-601 days) and lep-tospirosis-related death (median 27 days, range: 8-67 days) compared to PCR-negative dogs (median 402 days, range: 7-812 days) (P < 0.01). The neutrophil-to-lymphocyte ratio (NLR) in-dependently predicted leptospirosis-related death (HR = 1.073, 95%CI: 1.02-1.13, P = 0.01), while the BUN-to-creatinine ratio predicted all-cause mortality (HR = 1.02, 95% CI: 1.003-1.03, P = 0.02).
Conclusion:
Our findings underscore the severity of leptospirosis in older dogs, particularly those with azotemia or positive PCR results. NLR and BUN to creatinine ratios could be valuable tools for risk assessment and guiding treatment strategies in this vulnerable population.

Key words: Dog, Leptospira, Leptospirosis, PCR, Prognosis







Bibliomed Article Statistics

28
32
38
40
23
30
39
22
50
34
24
17
R
E
A
D
S

24

20

83

17

11

15

17

15

49

34

23

12
D
O
W
N
L
O
A
D
S
040506070809101112010203
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.